T3 Defense Amends $20M Private Placement, Correcting Warrant Exercise Price to $2.13
DFNS is trading near its 52-week low of $1.87 (10% above the low) on light trading volume (0.4× avg).
Summary
T3 Defense Inc. filed an amendment to its recent $20 million private placement, correcting a typographical error in the exercise price of the common stock warrants to $2.13 per share.
Key Events · Financing and Capital Events · DFNS
-
Correction to Warrant Exercise Price
The company amended its February 25, 2026 8-K filing to correct a typographical error regarding the exercise price of common stock warrants issued in the $20 million private placement. The correct initial exercise price is $2.13 per share.
-
Clarifies Terms of Significant Financing
This amendment provides crucial clarity on the terms of the substantial $20 million private placement, which involved convertible preferred stock and warrants. The original financing was announced on the same day as this amendment.
Analysis · DFNS · Trade & Services
This amendment clarifies a critical term of the recently announced $20 million private placement. The correction of the warrant exercise price from an unspecified 'incorrect' value to $2.13 per share is material for investors to accurately assess the potential dilution and future value of the warrants. While the original financing was highly dilutive, understanding the precise terms of the warrants is crucial for valuation, especially given the current stock price of $2.06.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DFNS was trading at $2.06 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $61M. The 52-week trading range was $1.87 to $26.21. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.